Study of an experimental drug in healthy people
Treatments studied
This trial is testing an investigational medication called GR2301 in healthy adults. It aims to see how the drug behaves in the body and if it is safe, which is a first step before studying it in people with medical conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be generally healthy, with no major medical conditions.
- Your body mass index (BMI) should be between 19 and 28, and you must weigh at least 50 kg (about 110 lbs) if you are a man, or 45 kg (about 99 lbs) if you are a woman.
- You should not have a history of drug abuse or substance use.
- If you are female, you must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called GR2301 in healthy volunteers to see if it is safe. It is a phase 1 study, which means it is the first time this drug is being given to people.
This trial tests a new drug called GR2303 to see if it is safe and how the body processes it. It is for healthy adults who have not used similar drugs before.
This is a first-in-human study of a new injected medication that may help with certain conditions. The trial is looking for healthy volunteers to check the drug's safety and how it works in the body.
This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This study tests a new investigational drug called ID110521156 in healthy adults. The goal is to see if the drug is safe and how the body processes it. It may be for people who are overweight or obese.
Hear when a new Multiple Dose trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.